Chronic Obstructive Pulmonary Disease

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.

Overview

Feature Articles

Latest Chronic Obstructive Pulmonary Disease News and Research

Older adults show interest in deprescribing, study reveals

Older adults show interest in deprescribing, study reveals

Black Americans more likely to die from causes related to air pollution, study finds

Black Americans more likely to die from causes related to air pollution, study finds

Study analyzes lack of palliative care referrals for nursing home residents

Study analyzes lack of palliative care referrals for nursing home residents

NYU Langone Health earns No. 1 spot in neurology and neurosurgery for the third straight year

NYU Langone Health earns No. 1 spot in neurology and neurosurgery for the third straight year

UQ study offers insights into how Haemophilus influenzae manipulates the immune system

UQ study offers insights into how Haemophilus influenzae manipulates the immune system

AI model accurately estimates pulmonary function from chest x-rays

AI model accurately estimates pulmonary function from chest x-rays

Global burden of heart failure: prevalence, incidence, and risk factors unveiled

Global burden of heart failure: prevalence, incidence, and risk factors unveiled

Research explores reversing memory loss with existing drugs

Research explores reversing memory loss with existing drugs

Adverse public health effects of air pollution on global population

Adverse public health effects of air pollution on global population

How micro- and nanoplastics may worsen non-communicable diseases

How micro- and nanoplastics may worsen non-communicable diseases

Study shows vaccines cut long COVID risk, especially for those with preexisting conditions

Study shows vaccines cut long COVID risk, especially for those with preexisting conditions

Exploring the comorbidities associated with osteoarthritis

Exploring the comorbidities associated with osteoarthritis

Novel insights into the underlying, contributing, and direct causes of death in Australia

Novel insights into the underlying, contributing, and direct causes of death in Australia

Transboundary ozone pollution significantly increases mortality rates in Europe

Transboundary ozone pollution significantly increases mortality rates in Europe

Statins found to prevent chronic inflammation-related cancers by inhibiting interleukin-33

Statins found to prevent chronic inflammation-related cancers by inhibiting interleukin-33

Dupilumab shows promise in cutting COPD flare-ups and boosting lung function

Dupilumab shows promise in cutting COPD flare-ups and boosting lung function

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Breakthrough study shows benefits of diagnosing hidden respiratory diseases

Breakthrough study shows benefits of diagnosing hidden respiratory diseases

New CT-derived functional imaging software enhances lung diagnosis without contrast dye

New CT-derived functional imaging software enhances lung diagnosis without contrast dye

Study finds accounting for sex improves precision and prognostic performance of CMR biomarkers for heart failure

Study finds accounting for sex improves precision and prognostic performance of CMR biomarkers for heart failure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.